KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 18,300,000 | $258,945,000 | 5.09% |
| EcoR1 Capital, LLC | 589,000 | $8,334,000 | 4.22% |
| Camber Capital Management LP | 3,000,000 | $42,450,000 | 2.82% |
| Cormorant Asset Management, LP | 1,000,000 | $14,150,000 | 2.18% |
| SECTORAL ASSET MANAGEMENT INC | 3,257,358 | $46,092,000 | 2.07% |
| Knoll Capital Management, LLC | 200,000 | $2,830,000 | 1.11% |
| OAK RIDGE INVESTMENTS LLC | 3,247,990 | $45,959,000 | 1.10% |
| NORTHPOINTE CAPITAL LLC | 514,445 | $7,279,000 | 0.87% |
| Apex Capital Management | 1,843,754 | $26,089,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,183,484 | $16,746,000 | 0.60% |